期刊
BRITISH JOURNAL OF CANCER
卷 127, 期 2, 页码 350-363出版社
SPRINGERNATURE
DOI: 10.1038/s41416-022-01789-4
关键词
-
类别
资金
- MEXT KAKENHI [19K16564, 20K21659, 20K19349]
- Grants-in-Aid for Scientific Research [20K19349, 20K21659, 19K16564] Funding Source: KAKEN
5-ALA can enhance intra-mitochondrial ROS production, increasing sensitivity of prostate cancer cells to radiation therapy. Combined use of 5-ALA and radiation therapy under hypoxic conditions can reduce cancer stemness and radiation resistance.
Background The naturally occurring amino acid 5-aminolevulinic acid (5-ALA) is a precursor of protoporphyrin IX (PpIX) biosynthesised in the mitochondria. When accumulated PpIX is excited by light (wavelength of 625-635 nm), reactive oxygen species (ROS) are generated. Here, we investigated whether 5-ALA may increase the sensitisation of prostate cancer (PCA) cells to radiotherapy through the generation of ROS via its metabolite, PpIX. Methods Effect of 5-ALA on PC-3 and DU-145 PCA cell lines treated with ionising radiation (IR) was examined in vitro and in vivo with assessment by clonogenic assay, mitochondrial function and ROS production under normoxia or hypoxia condition. Results 5-ALA enhanced intra-mitochondrial ROS production immediately after exposure to IR and decreased mitochondrial membrane potential via increase of intra-cellular PpIX. IR with 5-ALA induced mitochondrial dysfunction and increased ATP production, switching energy metabolism to the quiescence. Under hypoxic condition, ROS burst and mitochondrial dysfunction were induced by IR with 5-ALA resulting reducing cancer stemness and radiation resistance. Conclusion These results suggest that combined therapy with 5-ALA and radiation therapy is a novel strategy to improve the anti-cancer effects of radiation therapy for PCA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据